Related Experiment Video
Updated: Aug 7, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing
D L Smith1, M S Angst, J G Brock-Utne
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Background:
The object of this study was to test whether substituting part of the methohexital dose with the short-acting opioid remifentanil would prolong seizure duration in middle-aged patients while providing a similar depth of anesthesia as with methohexital alone. This has been reported for the combined use of methohexital and remifentanil in elderly patients, but has not been investigated in middle-aged patients likely to require a higher total dose of methohexital for inducing anesthesia.
Method:
Seven patients (42+/-10 years; mean +/-SD) receiving electroconvulsive therapy (ECT) were anesthetized with methohexital (1.25 mg kg-1) or with methohexital (0.625 mg kg-1) plus remifentanil (1 micro g kg-1) in this randomized, double blind, crossover study. Additional methohexital was given as needed until loss of eyelash reflex was observed. Suxamethonium (1 mg kg-1) was used for muscular paralysis.
Results:
Motor and EEG seizure durations were significantly longer after induction with methohexital plus remifentanil (45+/-14 and 58+/-15 s) than with methohexital alone (31+/-11 and 42+/-18 s). A methohexital dose of 1.2+/-0.3 and 1.9+/-0.3 mg was necessary to achieve loss of eyelash reflex if methohexital was used with and without remifentanil. Peak heart rate after ECT was significantly higher if remifentanil was coadministered with methohexital (148+/-12 vs. 126+/-24 b.p.m).
Conclusion:
Substituting part of the methohexital dose with remifentanil is a useful anesthetic technique to prolong seizure duration in middle-aged patients requiring a 1.5-fold higher induction dose of methohexital than elderly patients, the only population studied to date for the combined use of methohexital and remifentanil in ECT.
Insights
Substituting part of methohexital with remifentanil, an opioid, significantly prolonged seizure duration in middle-aged patients undergoing electroconvulsive therapy (ECT). This anesthetic technique offers a viable alternative for this patient group.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Electroconvulsive therapy (ECT) anesthesia often uses methohexital.
- Elderly patients have shown prolonged seizure duration with methohexital and remifentanil combination.
- Middle-aged patients may require higher methohexital doses, necessitating alternative anesthetic strategies.
Purpose of the Study:
- To evaluate if substituting part of the methohexital dose with remifentanil prolongs seizure duration in middle-aged patients.
- To determine if this combination provides anesthesia depth comparable to methohexital alone.
- To investigate anesthetic effects in middle-aged patients, a population not previously studied for this combination.
Main Methods:
- A randomized, double-blind, crossover study involving seven middle-aged patients undergoing ECT.
- Anesthesia was induced with either methohexital alone or a combination of methohexital and remifentanil.
- Additional methohexital was administered as needed to achieve loss of eyelash reflex; suxamethonium was used for paralysis.
Main Results:
- Methohexital combined with remifentanil significantly prolonged both motor and EEG seizure durations compared to methohexital alone.
- A lower total dose of methohexital was required when combined with remifentanil.
- Peak heart rate after ECT was significantly higher in the group receiving remifentanil.
Conclusions:
- Substituting part of the methohexital dose with remifentanil is an effective anesthetic technique for prolonging seizure duration in middle-aged patients.
- This approach is particularly useful as middle-aged patients require higher induction doses of methohexital than elderly patients.
- The findings extend the known benefits of methohexital-remifentanil combination in ECT anesthesia to a new patient demographic.
More Related Videos
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Seizures l: Introduction